[go: up one dir, main page]

NO20031838D0 - Benzokazinonderivater, deres fremstilling og anvendelse - Google Patents

Benzokazinonderivater, deres fremstilling og anvendelse

Info

Publication number
NO20031838D0
NO20031838D0 NO20031838A NO20031838A NO20031838D0 NO 20031838 D0 NO20031838 D0 NO 20031838D0 NO 20031838 A NO20031838 A NO 20031838A NO 20031838 A NO20031838 A NO 20031838A NO 20031838 D0 NO20031838 D0 NO 20031838D0
Authority
NO
Norway
Prior art keywords
benzocazine
derivatives
preparation
benzocazine derivatives
Prior art date
Application number
NO20031838A
Other languages
English (en)
Other versions
NO20031838L (no
Inventor
Christopher Norbert Johnson
Harshad Kantilal Rami
Geoffrey Stemp
Kevin Michael Thewlis
Mervyn Thompson
Antonio Kuok Keong Vong
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0026224A external-priority patent/GB0026224D0/en
Priority claimed from GB0111858A external-priority patent/GB0111858D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20031838D0 publication Critical patent/NO20031838D0/no
Publication of NO20031838L publication Critical patent/NO20031838L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20031838A 2000-10-26 2003-04-24 Benzoksazinonderivater, deres fremstilling av anvendelse NO20031838L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0026224A GB0026224D0 (en) 2000-10-26 2000-10-26 Novel compounds
GB0111858A GB0111858D0 (en) 2001-05-15 2001-05-15 Novel compounds
PCT/EP2001/012344 WO2002034754A2 (en) 2000-10-26 2001-10-22 Benzoxazinone derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
NO20031838D0 true NO20031838D0 (no) 2003-04-24
NO20031838L NO20031838L (no) 2003-06-24

Family

ID=26245199

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031838A NO20031838L (no) 2000-10-26 2003-04-24 Benzoksazinonderivater, deres fremstilling av anvendelse

Country Status (20)

Country Link
US (1) US6939871B2 (no)
EP (1) EP1330460B1 (no)
JP (1) JP4242643B2 (no)
KR (1) KR20030051747A (no)
CN (1) CN1478092A (no)
AR (1) AR034174A1 (no)
AT (1) ATE357448T1 (no)
AU (1) AU2002224791A1 (no)
BR (1) BR0114881A (no)
CA (1) CA2426706A1 (no)
CZ (1) CZ20031163A3 (no)
DE (1) DE60127434T2 (no)
ES (1) ES2280417T3 (no)
HU (1) HUP0301458A2 (no)
IL (1) IL155520A0 (no)
MX (1) MXPA03003820A (no)
NO (1) NO20031838L (no)
PL (1) PL366378A1 (no)
TW (1) TWI237023B (no)
WO (1) WO2002034754A2 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203804D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0203811D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0203778D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0209244D0 (en) * 2002-04-23 2002-06-05 Glaxo Group Ltd Compounds
MXPA05002003A (es) * 2002-09-26 2005-08-03 Warner Lambert Co Piperazinas sustituidas heterociclicas para el tratamiento de la esquizofrenia.
BR0315221A (pt) 2002-10-10 2005-08-23 Morphochem Ag Komb Chemie Compostos com atividade antibacteriana
KR100683361B1 (ko) 2002-11-08 2007-02-15 에프. 호프만-라 로슈 아게 치환된 벤즈옥사진온 및 그의 용도
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
EP1600067B1 (en) 2003-01-10 2012-12-12 Zuiko Corporation Wearing article and method of manufacturing the same
CA2523085A1 (en) * 2003-04-30 2004-11-18 Fmc Corporation Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
GB0310849D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
GB0310851D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
GB0316915D0 (en) 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
CN101365696A (zh) * 2004-07-28 2009-02-11 Irm责任有限公司 作为类固醇激素核受体调节剂的化合物和组合物
JP2009511530A (ja) * 2005-10-13 2009-03-19 モルフォケム アクチェンゲゼルシャフト フュア コンビナトリシェ ヘミー 抗菌活性を有する5−キノリン誘導体
CA2750047A1 (en) 2009-01-21 2010-07-29 Basilea Pharmaceutica Ag Novel bicyclic antibiotics
PT2513115E (pt) 2009-12-18 2013-12-19 Basilea Pharmaceutica Ag Antibióticos tricíclicos
US9321788B2 (en) 2011-06-17 2016-04-26 Basilea Pharmaceutica Ag Tricyclic antibiotics
SMT201900517T1 (it) 2017-03-20 2019-11-13 Forma Therapeutics Inc Composizioni di pirrolopirrolo come attivatori di piruvato chinasi (pkr)
US20200129485A1 (en) 2018-09-19 2020-04-30 Forma Therapeutics, Inc. Treating sickle cell disease with a pyruvate kinase r activating compound
CN113226356B (zh) 2018-09-19 2025-03-04 诺沃挪第克健康护理股份公司 活化丙酮酸激酶r
CN114615977B (zh) 2019-09-19 2025-01-14 诺沃挪第克健康护理股份公司 丙酮酸激酶r(pkr)活化组合物
US12128035B2 (en) 2021-03-19 2024-10-29 Novo Nordisk Health Care Ag Activating pyruvate kinase R

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2191180T3 (es) * 1996-05-29 2003-09-01 Warner Lambert Co Antagonistas de los receptores de la dopamina benzoxazinona d4.
EP0900792B1 (en) 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists
AU2494300A (en) * 1999-01-07 2000-07-24 American Home Products Corporation 3,4-dihydro-2h-benzo(1,4)oxazine derivatives
TW546299B (en) * 1999-01-07 2003-08-11 Wyeth Corp 3,4-dihydro-2H-benzo[1,4]oxazinyl-methyl-[3-(1H-indol-3-yl)-alkyl]-amines

Also Published As

Publication number Publication date
MXPA03003820A (es) 2003-07-28
EP1330460B1 (en) 2007-03-21
US6939871B2 (en) 2005-09-06
KR20030051747A (ko) 2003-06-25
HUP0301458A2 (hu) 2003-10-28
US20040063704A1 (en) 2004-04-01
WO2002034754A3 (en) 2002-07-11
IL155520A0 (en) 2003-11-23
ES2280417T3 (es) 2007-09-16
NO20031838L (no) 2003-06-24
JP4242643B2 (ja) 2009-03-25
CZ20031163A3 (cs) 2004-04-14
PL366378A1 (en) 2005-01-24
WO2002034754A2 (en) 2002-05-02
TWI237023B (en) 2005-08-01
CN1478092A (zh) 2004-02-25
BR0114881A (pt) 2003-09-30
ATE357448T1 (de) 2007-04-15
JP2004516250A (ja) 2004-06-03
AR034174A1 (es) 2004-02-04
AU2002224791A1 (en) 2002-05-06
EP1330460A2 (en) 2003-07-30
CA2426706A1 (en) 2002-05-02
DE60127434T2 (de) 2007-11-29
DE60127434D1 (de) 2007-05-03

Similar Documents

Publication Publication Date Title
NO20024742L (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO20014603L (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO20021449L (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
NO20012567D0 (no) Azepinoindolderivater, fremstilling og anvendelse derav
DK1455785T3 (da) Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse
NO20030596D0 (no) Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
DK1419150T3 (da) 1-Phenylsulfonyl-1,3-dihydro-2H-indol-2-on-derivater, deres fremstilling og deres terapeutiske anvendelse
NO20015113L (no) Nye forbindelser, deres fremstilling og anvendelse
NO20011956L (no) Substituerte fenylderivater, deres fremstilling og anvendelse
NO20025357L (no) Antranylamider og deres anvendelse som legemidler
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20023146L (no) Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
NO20032234D0 (no) Nye imidazolderivater, deres fremstilling og anvendelse
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse
NO20024105D0 (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO20001782D0 (no) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20012802L (no) Benzofuranderivater, deres fremstilling og anvendelse
NO996156L (no) Substituerte cykloheptener, deres fremstilling og anvendelse